As of 2025-09-17, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 11.8x | 9.1x |
| Forward P/E multiples | 10.4x - 16.4x | 12.3x |
| Fair Price | (49.87) - (56.04) | (51.26) |
| Upside | -172.8% - -181.8% | -174.8% |
| Date | EV/EBITDA |